| |
|
SHS Newsletter – To open this newsletter in your browser, please click here.
|
| |
|
|
|
| |
July 2015
|
|
|
|
|
|
| |
| |
|
Dear Sir or Madam,
|
| |
We have invested in two more exciting companies with our fourth fund. We procured shares in the highly innovative diagnostics company GNA Biosolutions and, with Novo Klinik-Service GmbH, we have fully acquired a supplier for care products as part of a succession plan. You can read more about this in our latest newsletter.
In the coming quarters, we will be seeking more companies to provide with growth capital or acquire entirely.
We hope you enjoy reading and look forward to your feedback.
Greetings from Tübingen,
|
| |
|
| |
|
Hubertus Leonhardt
|
|
|
|
| |
| |
|
Topics
|
| |
| • |
Tuned prostheses and other future medical technology trends
|
| |
|
|
|
| • |
SHS acquires the medical technology company Novo
|
| |
|
|
| • |
SHS acquires shares of molecular diagnostics specialist GNA Biosolutions
|
| |
|
|
| • |
Carla Kikken-Jussen strengthens the Vimecon management team
|
| |
|
|
|
| • |
SHS partners lecture at TU München
|
| |
|
|
| • |
Armin Bolz joins SHS team as Venture Advisor
|
| |
|
|
|
|
|
| • |
Jobs at SHS portfolio companies
|
| |
|
|
|
| • |
Selected press articles from May 2015 on
|
| |
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
| |
| |
| Tuned prostheses and other future medical technology trends |
| |
| From regenerative medicine to additive manufacturing – future trends in medical technology vary widely. Dr. Martin Laqua takes a look at future industry developments. Our guest author is biologist and Editor in Chief of the medical technology portal Medtech Zwo – a platform provided by BIOCOM AG. |
| |
|
Read more »
|
| |
|
|
.jpeg "Dr. Matrin Laqua")
|
|
|
| |
|
|
| |
Guest author Dr. Martin Laqua, Editor in Chief at Medtech Zwo
|
|
| |
|
|
|
|
|
|
| |
| |
| SHS acquires the medical technology company Novo |
| |
| With its current Fund IV, SHS has acquired all the shares of Novo Klinik-Service GmbH. The company is based in Kerpen, Germany and specializes in the production and sale of medical fixation and pad systems as well as medical technology solutions. |
| |
|
Read more »
|
| |
|
|
.jpeg "Novo Beteiligung")
|
|
|
| |
|
|
| |
Breathable fixations and pads offer hold and optimal protection against skin irritation
|
|
| |
|
|
|
| |
| |
| |
| SHS acquires shares of molecular diagnostics specialist GNA Biosolutions |
| |
| SHS has invested in GNA Biosolutions GmbH together with existing and new investors. GNA enables robust detection of pathogens using a laser-based PCR method. Physicians and hospitals can diagnose such bacterial diseases within minutes without time-consuming laboratory work. |
| |
|
Read more »
|
| |
|
|
|
|
|
| |
|
|
| |
The Pharos400 with its Laser PCR technology enables an ultrafast DNA amplification
|
|
| |
|
|
|
| |
| |
| |
| Carla Kikken-Jussen strengthens the Vimecon management team |
| |
| Vimecon has welcomed Carla Kikken-Jussen to its management team. As Vice President, she will be responsible for clinical development and regulatory issues. |
| |
|
Read more »
|
| |
|
|
.jpeg "Vimecon Kikken-Jussen")
|
|
|
| |
|
|
| |
Carla Kikken-Jussen has joined Vimecon management team
|
|
| |
|
|
|
|
|
|
| |
| |
| SHS partners lecture at TU München |
| |
| Dr. Bernhard Schirmers and Hubertus Leonhardt held lectures on the subject of investment management and fundraising as part of the Certified Private Equity Analyst training program at TU München. |
| |
|
Read more »
|
| |
|
|
.jpeg "TUM Abschluss")
|
|
|
| |
|
|
| |
CPEA students from the 2014/2015 year with TUM professor Dr. Christoph Kaserer (second from the left)
|
|
| |
|
|
|
| |
| |
| |
| Armin Bolz joins SHS team as Venture Advisor |
| |
| The managing partner of Corscience GmbH & Co. KG, Professor Dr. Armin Bolz, will be bolstering the SHS team as Venture Advisor. |
| |
|
Read more »
|
| |
|
|
|
|
|
| |
|
|
| |
Professor Dr. Armin Bolz supports SHS as Venture Advisor
|
|
| |
|
|
|
|
|
|
| |
| |
| |
| Jobs at SHS portfolio companies |
| |
Managing Director/MBI candidate (m/f) for medical technology in Southern Germany/Switzerland
Read more »
Innovative special pharmaceutical company is seeking a Business Development Manager with the prospect of becoming Managing Director
Read more »
CFO (m/f) Life Sciences
Read more » |
| |
|
|
|
|
|
|
| |
| |
| Selected press articles from May 2015 on |
| |
Frankfurter Allgemeine Zeitung, May 8th, 2015: „Investor stößt in neues Segment vor – Start-up-Spezialist SHS erwirbt nun auch größere Firmen“ (Investor enters new segment - start-up specialist SHS is now acquiring larger companies)
SHS has entered the medium-sized investment segment with its new fourth fund, for which it attracted 125 million euro. SHS is seeking to also invest in established small and medium-sized companies in the future.
Read more »
mergermarket, May 14th, 2015: "SHS has acquisitions in the pipeline, looks for advisors to assist sale processes”
SHS is seeking advisors to support it in identifying possible investments. With its new fourth fund, SHS is seeking to invest in companies with transaction volumes of up to 100 million euro in the next five years.
Read more »
transkript, June 2015: „Deutsche Börse Venture Network zur Wachstumsfinanzierung wird konkret“ (Deutsche Börse Venture Network for growth financing takes shape)
The "Deutsche Börse Venture Network" was launched in June as a program consisting of a non-public online platform to form financing rounds as well as a wide array of training and networking events. SHS is participating on the investor side.
Read more » |
| |
|
|
|
|
|
| |
|
|
| |
|
|
| |
Investment focus
|
|
| |
|
|
| |
| Sector: |
|
life sciences (medical technology, diagnostics, applied technologies, industrial biotechnology/pharmaceutical industry; no drug development) |
| Geographical Focus: |
|
Germany, Austria, Switzerland |
| Reasons for investment: |
|
growth capital, strengthening equity, MBO/MBI, change of shareholders/succession, M&A financing, spin-off |
| Company situation: |
|
growth/expansion, succession/company sale, internationalization; operating profit may be negative for growth, or for technology-related reasons |
| Transaction value and investment size: |
|
transaction value: up to € 100 mn; investment amount SHS IV: € 2-20 mn, with a co-investor up to € 50 mn |
| Investment types: |
|
majorities or minorities, equity & financial instruments similar to equity |
|
|
| |
|
|
| |
|
|
|
|
|
| |
|
|
| |
|
The SHS Newsletter is
published by:
SHS Gesellschaft für Beteiligungsmanagement mbH
|
|
Bismarckstrasse 12
72072 Tuebingen
Germany
www.shsvc.net
|
|
Tel +49 7071 9169-0
Fax +49 7071 9169-190
To unsubscribe the newsletter, please click here.
|
|
|
| |
|
|
| |
Editorial team: SHS Gesellschaft für Beteiligungsmanagement mbH, Ira Wülfing Kommunikation GmbH | Design and technical realisation: UNIBRAND GmbH, Ira Wülfing Kommunikation GmbH
To open this newsletter as a PDF file please click here.
|
|
| |
|
|
|
|
| |
|